Target Price | €11.90 |
Price | €2.64 |
Potential |
350.76%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a Heidelberg Pharma price target 2026.
The average Heidelberg Pharma target price is €11.90.
This is
350.76%
register free of charge
|
|
A rating was issued by 1 analysts: 1 Analysts recommend Heidelberg Pharma to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Heidelberg Pharma stock has an average upside potential 2026 of
350.76%
register free of charge
|
Nov '23 |
2024 Estimates |
|
---|---|---|
Revenue Million € | 9.86 | 11.50 |
46.73% | 16.63% | |
EBITDA Margin | -270.18% | -162.61% |
182.55% | 39.81% |
1 Analyst has issued a sales forecast Heidelberg Pharma 2024 . The average Heidelberg Pharma sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Heidelberg Pharma 2024 . The average Heidelberg Pharma EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Nov '23 |
2024 Estimates |
|
---|---|---|
EV/Sales | 9.37 |
Analyst | Rating | Action | Date |
---|---|---|---|
PARETO SECURITIES AS |
Locked
➜
Locked
|
Locked | Oct 09 2024 |
Analyst Rating | Date |
---|---|
Locked
PARETO SECURITIES AS:
Locked
➜
Locked
|
Oct 09 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.